2017 tables: Institutions - chemistry - corporate

The 2017 tables are based on Nature Index data from 1 January 2016 to 31 December 2016.

Table criteria

# Institution Share 2015 Share 2016 Count 2016 Change in Adjusted Share 2015-2016*
1 Merck & Co., Inc., United States of America (USA) 16.85 23.35 38 47.3%
2 IBM Corporation, United States of America (USA) 22.48 15.97 33 -24.5%
3 AstraZeneca plc, United Kingdom (UK) 13.10 15.42 55 25.1%
4 F. Hoffmann-La Roche AG, Switzerland 8.82 15.09 30 81.9%
5 Pfizer Inc., United States of America (USA) 10.17 13.69 23 43.1%
6 Novartis International AG, Switzerland 14.96 10.77 27 -23.5%
7 GlaxoSmithKline plc. (GSK), United Kingdom (UK) 14.40 10.44 32 -23.0%
8 C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim), Germany 6.75 8.08 16 27.4%
9 BASF SE, Germany 7.30 7.01 33 2.2%
10 Toyota Group, Japan 8.69 6.90 15 -15.6%
11 Amgen Inc., United States of America (USA) 5.53 6.87 11 32.2%
12 Dow Inc., United States of America (USA) 7.39 6.49 21 -6.6%
13 Thermo Fisher Scientific Inc., United States of America (USA) 4.40 6.18 25 49.3%
14 Samsung Group, South Korea 6.56 5.76 24 -6.6%
15 Bristol-Myers Squibb (BMS), United States of America (USA) 7.75 3.96 13 -45.7%
16 Bruker Corporation, United States of America (USA) 4.59 3.42 24 -20.7%
17 Shimadzu Corporation, Japan 0.01 2.92 10 20,668.2%
18 Mitsubishi Group, Japan 2.77 2.90 17 11.2%
19 China National Chemical Corporation (ChemChina), China 4.17 2.87 12 -26.8%
20 Johnson & Johnson, United States of America (USA) 3.41 2.65 5 -17.2%
21 China Shipbuilding Industry Corporation (CSIC), China 1.65 2.58 22 66.4%
22 FiberHome Technologies Group, China 1.65 2.54 20 63.8%
23 Exxon Mobil Corporation (ExxonMobil), United States of America (USA) 1.66 2.40 13 53.3%
24 HRL Laboratories LLC, United States of America (USA) 1.28 2.31 3 92.0%
25 HP Inc., United States of America (USA) 0.50 2.13 3 347.5%
26 Center for Nanotechnology GmbH (CeNTech GmbH), Germany 2.89 2.07 11 -23.9%
27 AbbVie Inc., United States of America (USA) 1.06 2.03 4 103.2%
28 Waters Corporation, United States of America (USA) 4.44 2.02 7 -51.6%
29 Seattle Genetics, Inc., United States of America (USA) 1.00 2.00 2 112.6%
29 Q2 Solutions, United States of America (USA) 2.00 2 N/A
30 Chengdu Institute of Organic Chemistry (CIOC), CAS, China 1.99 1.92 8 2.7%
31 Shanghai Jiahua Poly Battery Technology Co., Ltd., China 0.81 1.89 5 147.7%
32 Johnson Matthey (JM), United Kingdom (UK) 2.99 1.86 5 -34.0%
33 Sanofi, France 4.48 1.84 4 -56.3%
34 Agilent Technologies, Inc., United States of America (USA) 2.06 1.83 6 -5.5%
35 Formosa Plastics Group, Taiwan 2.32 1.81 6 -16.8%
36 Biogen Inc., United States of America (USA) 1.80 3 N/A
37 Eli Lilly and Company, United States of America (USA) 3.40 1.76 10 -44.9%
38 Panasonic Corporation, Japan 1.70 5 N/A
39 Koninklijke DSM N.V. (DSM), Netherlands 3.70 1.70 6 -51.2%
40 Jinchuan Group Co., Ltd., China 1.55 1.68 10 15.3%
41 Takeda Pharmaceutical Company Limited, Japan 3.81 1.61 8 -54.9%
42 Solvay S.A., Belgium 1.17 1.57 6 42.1%
43 Takasago International Corporation, Japan 1.57 3 N/A
44 Colgate-Palmolive Company, United States of America (USA) 1.49 3 N/A
45 Merck KGaA, Germany 2.23 1.48 10 -29.4%
46 Novo Nordisk A/S, Denmark 1.55 1.46 4 0.0%
47 Zhejiang NHU Company Ltd., China 1.41 1.36 3 2.7%
48 Siemens AG, Germany 1.07 1.35 8 33.9%
49 Haldor Topsøe A/S, Denmark 0.71 1.35 6 102.4%
50 Foxconn Technology Group, Taiwan 1.03 1.34 6 38.0%

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at natureindex.com.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2020 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.